Dr. Aaron P. Scott, MD
Emergency Medicine (Emergency Medicine Physician)
835 Se Bishop Blvd
Pullman, WA 99163
Who else practices at this address →
Whitman County is a federal mental health shortage area. About shortage areas
At a glance
- Medical school
- Wake Forest University School of Medicine (1995)
- Years since graduation
- 31
- In the NPI registry since
- 2005
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1995Medical school: Wake Forest University School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Emergency Medicine Physician primary
WA license MD00044362 -
Family Medicine Physician
WA license MD00044362
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Pullman Regional Hospital Pullman, WA
- Whitman Hospital and Medical Center Colfax, WA
Medical groups
- Community Health Association of Spokane (221 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Cephalexin Other prescribers in Pullman, WA | 15 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $96,124 in research payments for these studies, mostly to the institutions running them.
- A Phase 1/1b First- in -Human Trial of BMS-986484 as Monotherapy and in Combination Therapies in Participants with Advanced Solid Malignancies
E.r. Squibb & Sons, L.l.c. - A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
E.r. Squibb & Sons, L.l.c. · Active, not recruiting · NCT06544655
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.